Mónica Cejuela Solís

8PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry and metabolomics not elsewhere classifiedEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 10, 2026
Expert consensus on optimal management of liver-related adverse events during CDK4/6 inhibitor therapy.

|Mar 06, 2026
UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer.

Ana Gil-Torralvo, M Ángeles Domínguez-Cejudo, Sonia Molina-Pinelo

|Jun 13, 2025
RETRACTED: Cejuela et al. Metformin and Breast Cancer: Where Are We Now? Int. J. Mol. Sci. 2022, 23, 2705.

Mónica Cejuela, Begoña Martin-Castillo, Javier A Menendez

|Dec 09, 2023
Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities.

María A Domínguez-Cejudo, Ana Gil-Torralvo, Mónica Cejuela

|May 27, 2023
Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer.

Mónica Cejuela, Ana Gil-Torralvo, M Ángeles Castilla

|May 09, 2023
Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study.

Manuel Sánchez-Cánovas, Paula Jimenez-Fonseca, David Fernández Garay

Pageof 2

Frequent Collaborators

4 joint publications

Sonia Pernas

3 joint publications

Sonia Molina-Pinelo

2 joint publications

Javier A Menendez

1 joint publications

Javier Salvador Bofill